Prader-Willi-Syndrom (PWS) Markt GRÖSSEN- UND MARKTANTEILSANALYSE - WACHSTUMSTRENDS UND PROGNOSEN (2024 - 2031)

Prader-Willi-Syndrom (PWS) Markt wird durch Wachstumshormontherapie (GENOTROPIN, NORDITROPIN, OMNITROPE), By Hyperphagia Treatment (DCCR, Carbetocin, ARD-101), By Behavioral and Sleep Management (WAKIX), By Geography (Nordamerika, Lateinamerika, Asien-Pazifik, Europa, Mittlerer Osten und Afrika) segmentiert. Der Bericht bietet den Wert (in Mrd. USD) für die oben genannten Segmente.

Competitive overview of Prader-Willi-Syndrom (PWS) Markt

Zu den wichtigsten Akteuren im Prader-Willi-Syndrom (PWS) Markt gehören Soleno Therapeutics, Harmony Biosciences, Pfizer, Novo Nordisk, Sandoz, ACADIA Pharmaceuticals, Aardvark Therapeutics, Gedeon Richter, Palobiofarma und ConSynance Therapeutics.

Prader-Willi-Syndrom (PWS) Markt Leaders

  • Soleno Therapie
  • Harmony Biowissenschaften
  • Pfeifen
  • Novo Nordisk
  • Sandoz
*Disclaimer: Major players are listed in no particular order.

Prader-Willi-Syndrom (PWS) Markt - Competitive Rivalry, 2023

Market Concentration Graph

Prader-Willi-Syndrom (PWS) Markt

Market Consolidated
(Dominated by major players)
Market Fragmented
(Highly competitive with lots of players.)
*Source: Coherent Market Insights

Prader-Willi-Syndrom (PWS) Markt Report Snapshots

Buy Now